FdaApplication
BLA 761073
Identifiers
- fda_app_no: BLA761073
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2019-06-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KANJINTI | TRASTUZUMAB-ANNS | 150MG | For Injection |
| KANJINTI | TRASTUZUMAB-ANNS | 420MG | VIAL;MULTIDOSE |
2 products